We are live on ! Find out more
1CM

1492 Capital Management Portfolio holdings

AUM $263M
1-Year Est. Return 61.9%
This Fund
S&P 500
This Quarter Est. Return
-18.23%
1 Year Est. Return
+61.9%
3 Year Est. Return
+187.15%
5 Year Est. Return
+242.53%
10 Year Est. Return
+2,731.07%
AUM
$112M
AUM Growth
-$42.1M
Cap. Flow
-$9.44M
Cap. Flow %
-8.46%
Top 10 Hldgs %
37.03%
Holding
115
New
23
Increased
16
Reduced
44
Closed
26

Sector Composition

Rank Sector Weight
1 Healthcare 28.38%
2 Technology 25.15%
3 Consumer Discretionary 12.04%
4 Industrials 6.25%
5 Financials 6.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SKX
101
CALL
DELISTED
Skechers
SKX
-8,600
Closed -$240K
TTSH
102
DELISTED
Tile Shop Holdings
TTSH
-134,868
Closed -$964K
WTFC icon
103
Wintrust Financial
WTFC
$11B
-2,816
Closed -$239K
ACCS
104
ACCESS Newswire
ACCS
$26.4M
-47,352
Closed -$724K
ATSG
105
DELISTED
Air Transport Services Group
ATSG
-107,451
Closed -$2.31M
CPE
106
DELISTED
Callon Petroleum Company
CPE
-24,017
Closed -$2.88M
CHS
107
DELISTED
Chicos FAS, Inc.
CHS
-208,294
Closed -$1.81M
TRHC
108
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
-12,211
Closed -$991K
FRGI
109
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
-35,158
Closed -$940K
TLRD
110
DELISTED
Tailored Brands, Inc.
TLRD
-47,113
Closed -$1.19M
IDTI
111
DELISTED
Integrated Device Technology I
IDTI
-38,984
Closed -$1.83M
NTRI
112
DELISTED
NutriSystem, Inc.
NTRI
-6,358
Closed -$236K
OCLR
113
DELISTED
Oclaro Inc.
OCLR
-25,245
Closed -$226K
CY
114
DELISTED
Cypress Semiconductor
CY
-180,695
Closed -$2.62M
ATTU
115
DELISTED
Attunity Ltd
ATTU
-91,847
Closed -$1.74M

Similar funds

1492 Capital Management's Q4 2018 Portfolio in Review

As of Q4 2018, 1492 Capital Management held 115 positions worth $112M, down 27% from $154M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

1492 Capital Management withdrew a net $9.44M in Q4 2018, closing 26 positions and reducing 44 holdings. Its most notable exit was Dycom Industries, an estimated $2.89M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 20% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, 1492 Capital Management opened a new position in Collegium Pharmaceutical worth $2.58M.

  • 1492 Capital Management's largest Q4 2018 buy was Collegium Pharmaceutical: 150,189 shares worth $2.58M.
  • 1492 Capital Management added most to BioDelivery Sciences International, Inc. in Q4 2018, an estimated $1.97M increase.
  • 1492 Capital Management's biggest Q4 2018 reduction was BioTelemetry, Inc., cutting an estimated $2.2M.
  • 1492 Capital Management fully exited Dycom Industries in Q4 2018, selling an estimated $2.89M.
  • 1492 Capital Management's ten largest holdings make up 37% of its $112M portfolio in Q4 2018.
  • 1492 Capital Management opened 23 new positions and closed 26 in Q4 2018.
  • 1492 Capital Management's portfolio value fell 27% quarter-over-quarter to $112M.

Based on 1492 Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.